Cost-Effectiveness Analysis of Triple Therapy With Peginterferon, Ribavirin, And Boceprevir For The Treatment of Chronic Hepatitis C Virus Genotype 1 With Severe Fibrosis Under “Real-Life” Conditions | Publicación